STOCK TITAN

Clarivate Prices 2028 Debt Buyback at $975.15

Accepted holders would receive $975.15 per $1,000 principal amount, plus accrued interest through but excluding the expected September 25, 2026 settlement date.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

CLARIVATE PLC announced pricing terms for a cash tender offer by its wholly owned subsidiary, Clarivate Science Holdings Corporation, for its 3.875% Senior Secured Notes due 2028. The offer has a $75,000,000 aggregate-principal cap, subject to proration and other conditions. The stated Total Consideration is $975.15 per $1,000 principal amount validly tendered for purchase, plus accrued and unpaid interest for notes accepted. The notes had $825,000,000 in aggregate principal amount outstanding.

The pricing uses a 4.864% Reference Yield and a +50-basis-point Fixed Spread. The offer expires at 5:00 p.m. New York City time on September 23, 2026, unless extended or earlier terminated. The subsidiary may change the Tender Cap before expiration and may accept up to 2% more of the outstanding notes without amending or extending the offer. Settlement was expected September 25, 2026.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Tender Cap $75,000,000 Aggregate principal amount of notes purchased, subject to proration
Total Consideration $975.15 per $1,000 principal amount For notes validly tendered for purchase
Aggregate principal amount outstanding $825,000,000 3.875% Senior Secured Notes due 2028
Reference Yield 4.864% Tender offer pricing
Fixed Spread +50 basis points Tender offer pricing
Expiration deadline 5:00 p.m. New York City time on September 23, 2026 Unless extended or earlier terminated
Expected Settlement Date September 25, 2026 Expected settlement date for the offer
Notes' stated interest rate 3.875% Senior Secured Notes due 2028
Tender Cap financial
"subject to a $75,000,000 cap on the aggregate principal amount"
A tender cap is the maximum number of shares or maximum total value a buyer will accept in a tender offer, essentially a limit on how much stock the bidder is willing to buy. It matters to investors because if more shares are tendered than the cap allows, the buyer will scale back purchases proportionally, like selling a fixed number of tickets when demand is higher than supply, which affects how many shares each holder can sell and the likely outcome of the offer.
Total Consideration financial
"Total Consideration payable per each $1,000 principal amount"
Total consideration is the full amount of value exchanged in a transaction, including all payments, assets, or benefits involved. It represents what is given up or received in a deal, much like the total price paid when buying a house, covering both the purchase price and any additional costs or benefits. For investors, understanding total consideration helps assess the true scale and value of a transaction.
Reference Yield financial
"Reference Yield based on the bid-side price of the Reference Security"
The reference yield is the standard rate of return on a debt security, like a government bond, that investors expect to earn if they buy it at its current price. It acts like a benchmark, helping investors compare different bonds and decide if they are worth buying, much like checking the interest rate on a savings account to see how much you will earn over time.
Fixed Spread financial
"based on the Fixed Spread, plus the Reference Yield"
A fixed spread is a set difference between the buying and selling prices of a financial instrument that remains constant regardless of market conditions. For investors, this means the cost to trade stays predictable, making it easier to understand potential expenses and plan accordingly—similar to a fixed fee in a service that doesn’t change, no matter how busy or slow the market becomes.
proration financial
"subject to proration and the terms and conditions"
Proration is the method of dividing a limited quantity—such as shares in an offering, dividends, or rights—among claimants when demand exceeds supply, so each participant receives a proportional slice rather than the full amount requested. It matters to investors because proration determines how many shares or what portion of a payout they actually receive, which affects portfolio size, cash needs, and the expected return; think of it as splitting a pie fairly when more people want a piece than there are slices.
Accrued Coupon Payment financial
"the payment thereof, the Accrued Coupon Payment"
An accrued coupon payment is the interest earned on a bond that has accumulated since the last payment date but has not yet been paid to the investor. Think of it like interest building up in a savings account that will be paid out later; it reflects the amount the investor is owed for holding the bond during that period. This figure matters because it helps accurately determine the bond’s current value and the investor’s true earnings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is CLVT offering for each $1,000 of its 2028 notes?

The stated Total Consideration is $975.15 per $1,000 principal amount validly tendered for purchase. Holders whose notes are accepted also receive accrued and unpaid interest from the last interest payment date to, but excluding, the Settlement Date.

What is CLVT's tender cap for the 2028 notes?

The subsidiary's Tender Cap is $75,000,000 in aggregate principal amount of notes purchased, subject to proration. It may, but is under no obligation to, eliminate, increase or decrease the cap before expiration; it may accept up to 2% more of the outstanding notes without amending or extending the offer.

Until when can CLVT noteholders withdraw tendered notes?

Notes may be validly withdrawn at or before 5:00 p.m. New York City time on September 23, 2026. After that, they may not be validly withdrawn, except as provided in the Offer to Purchase or required by applicable law.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001764046 0001764046 2026-09-23 2026-09-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): September 23, 2026

 

CLARIVATE PLC

(Exact name of registrant as specified in its charter)

 

Jersey, Channel Islands
(State or other jurisdiction of incorporation or organization)

 

001-38911
(Commission File Number)

 

N/A
(I.R.S. Employer Identification No.)

 

70 St. Mary Axe

London EC3A 8BE

United Kingdom

 

(44) 207-433-4000 

Registrant's telephone number, including area code

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Ordinary Shares, no par value CLVT New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01. Other Events.

 

On September 23, 2026, Clarivate Plc issued a press release announcing the pricing terms of the previously announced cash tender offer by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

No. Description
99.1 Press release issued by Clarivate Plc dated September 23, 2026
104 Cover page of this Current Report on Form 8-K formatted in Inline XBRL

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  CLARIVATE PLC
   
Date: September 23, 2026 By: /s/ John Doulamis
  Name: John Doulamis
 

Title: Senior Vice President, General Counsel 

 

 

 

 

Exhibit 99.1

 

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

 

LONDON, September 23, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase").

 

The Company is offering to purchase in the Offer its 3.875% Senior Secured Notes due 2028 (the "Notes") for the consideration described below, subject to a $75,000,000 cap on the aggregate principal amount of Notes purchased in the Offer (the "Tender Cap") subject to proration and the terms and conditions set forth in the Offer to Purchase. Subject to applicable law, the Company may, but is under no obligation to, eliminate, increase or decrease the Tender Cap at any time prior to the "Expiration Date" of 5:00 p.m., New York City time, on September 23, 2026 (unless extended or earlier terminated by the Company). In the event proration is required with respect to the Notes, the Company will multiply the principal amount of each valid tender of such Notes by the proration rate and round the resulting amount down to the nearest $1,000 principal amount in order to determine the principal amount of such tender that will be accepted pursuant to the Offer. The excess principal amount of Notes not accepted from the tendering Holders will be promptly returned to such Holders, and if this excess principal amount of Notes is less than $2,000, the Company may either accept or reject all such tendering Holders' validly tendered Notes in its sole discretion. Additionally, the Company may increase the amount of Notes accepted for payment in the Offer by no more than 2% of the outstanding Notes without amending or extending the Offer. The Offer to Purchase and any related documents are referred to herein collectively as the "Tender Offer Documents". Capitalized terms used but not defined in this press release have the meanings given to them in the Offer to Purchase.

 

Certain information regarding the Notes and the pricing for the Offer is set forth in the table below.

 

 

Notes

Issuer

CUSIP / ISIN Number(1)

Aggregate

Principal Amount Outstanding

Reference Security

Reference Yield(2)

Bloomberg Reference Page Fixed Spread (Basis Points)

Total

Consideration(3)

3.875% Senior Secured Notes due 2028 Clarivate Science Holdings Corporation

144A: 18064P AC3 / US18064PAC32

 

Reg S: U1800Q AC3 / USU1800QAC34

$825,000,000 4.125% UST due June 30, 2028 4.864% FIT 4 +50 $975.15

 

(1)No representation is made as to the correctness or accuracy of the CUSIP or ISIN numbers listed above.

(2)The Reference Yield was determined at 2:00 p.m., New York time, on September 23, 2026.

(3)Represents the total consideration for the Notes (the "Total Consideration") payable per each $1,000 principal amount of the Notes validly tendered and accepted for purchase in the Offer.

 

 

 

The "Total Consideration" payable per each $1,000 principal amount of Notes validly tendered for purchase is based on the Fixed Spread, plus the Reference Yield based on the bid-side price of the Reference Security as quoted on the Bloomberg Reference Page as of 2:00 p.m., New York City time, today, September 23, 2026 (the "Price Determination Date"). In addition to the Total Consideration, Holders whose Notes are accepted for purchase pursuant to the Offer will receive accrued and unpaid interest on those Notes from the last interest payment date with respect to those Notes to, but excluding, the Settlement Date (the "Accrued Interest," and the payment thereof, the "Accrued Coupon Payment").

 

Tenders of Notes may be validly withdrawn at any time at or prior to 5:00 p.m., New York City time, today, September 23, 2026 (the "Withdrawal Deadline"), but, except as provided in the Offer to Purchase or required by applicable law, may not be validly withdrawn thereafter. The "Settlement Date" will be the second business day after the Expiration Date and is expected to be September 25, 2026.

 

The complete terms and conditions of the Offer are set forth in the Tender Offer Documents. Holders are urged to read the Tender Offer Documents carefully. If any condition to the Offer is not satisfied or waived, the Company is not obligated to accept for payment, purchase or pay for, and may delay the acceptance for payment of, any tendered Notes, in each case subject to applicable law, and may terminate or alter the Offer.

 

The Company has retained Citigroup Global Markets Inc. to act as dealer manager (the "Dealer Manager") for the Offer. Global Bondholder Services Corporation will act as the Tender and Information Agent for the Offer. For additional information, please contact: Citigroup Global Markets Inc. at +1 (800) 558-3745 (toll-free) or +1 (212) 723-6106 (collect). Requests for documents and questions regarding the tendering of Notes may be directed to Global Bondholder Services Corporation by telephone at (212) 430-3774 (for banks and brokers only) and (855) 654-2015 (for all others toll-free) or to the Dealer Manager at its telephone number. Copies of the Offer to Purchase are available at: https://www.gbsc-usa.com/clarivate/. You may also contact your broker, dealer, commercial bank, trust company or other nominee for assistance concerning the Offer.

 

Holders of Notes are advised to check with each bank, securities broker or other intermediary through which they hold Notes as to when such intermediary would need to receive instructions from a beneficial owner in order for that Holder to be able to participate in, or withdraw their instruction to participate in the Offer before the deadlines specified herein and in the Offer to Purchase. The deadlines set by any such intermediary and DTC for the submission and withdrawal of tender instructions may be earlier than the relevant deadlines specified herein and in the Offer to Purchase.

 

This press release is neither an offer to purchase nor a solicitation of an offer to sell the Notes or any other securities. The Offer is made only by and pursuant to the terms of the Offer to Purchase and only to such persons and in such jurisdictions as is permitted under applicable law. The information in this press release is qualified by reference to the Offer to Purchase. None of the Company, Clarivate, the Dealer Manager or the Tender and Information Agent makes any recommendation as to whether Holders should tender their Notes pursuant to the Offer. Holders must make their own decisions as to whether to tender Notes, and, if so, the principal amount of Notes to tender.

 

 

 

Forward-Looking Statements

 

This release includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements” within the meaning of the “safe harbor provisions” of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include all matters that are not historical facts, including statements relating to our intentions, beliefs, or current expectations concerning, among other things, the completion of the Offer. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will,” or “should” or, in each case, their negative or other variations or comparable terminology. Such forward-looking statements are based on available current market material and management’s expectations, beliefs, and forecasts concerning future events impacting us. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in Item 1A. Risk Factors in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). There can be no assurance that future developments affecting us will be those that we have anticipated. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Please consult our public filings with the SEC, which are also available on our website at www.clarivate.com.

 

About Clarivate

 

Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property, and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.

 

Media Contact:

Amy Bourke-Waite, Senior Director, Communications & Brand

newsroom@clarivate.com

 

Investor Relations Contact:

Mark Donohue, Vice President, Investor Relations

investor.relations@clarivate.com

 

 

Filing Exhibits & Attachments

4 documents

Keep reading